Get Started

ASMB

NASD Assembly Biosciences, Inc.
Oct 31, 2026 · 4:54 AM ET EOD Market Closed

$20.13 ↑ +0.00 (+0.00%) Trading Up from the previous close of $20.13, $0.87 below the day’s high of $21.00

YTD change
-40.81%
vs 20-day SMA
-5.13%
vs 200-day SMA
-26.15%

Price ranges

Previous day
$19.98 $21.00
open $20.86 close $20.13
-$0.73 (-3.50%)
Today
$19.98 $21.00
$20.13
Past week
$19.30 $21.36
from $20.28 now $20.13
-$0.15 (-0.74%)
Past month
$19.30 $23.83
from $22.98 now $20.13
-$2.85 (-12.40%)
This year
$19.30 $37.01
from $34.01 now $20.13
-$13.88 (-40.81%)

Price & Performance

-7.24 (-26.45%) / 6M

$18.31$24.90$31.49$38.08May 1Aug 3Oct 30

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Poor
  • The stock is 97.5% away from all-time highs of $808.32
  • ASMB is down 41% since the beginning of the year
  • ASMB is down 33% over the past 12 months
  • ASMB is down 12% over the past 1 month
  • 19% of all ASMB investors are betting against ASMB

ASMB reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -35.2%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.2
Earnings momentum +69.5% Quarterly EPS growth
Quarterly change +69.5%

Valuation

P/E ratio 20.17
Enterprise value $75.3M
Beta 1.19

Balance sheet & scale

IncomeN/A
Revenue$74.8M
Cash$320.4M
Debt$2.4K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $409.8M

Assembly Biosciences, Inc. is a biotechnology company that focuses on developing small molecule antiviral therapeutics for serious viral diseases. Its lead programs, ABI-5366 and ABI-1179, long-acting helicase-primase inhibitors, are in clinical development for recurrent genital herpes. The company is partnered with Gilead Sciences to advance current and future antiviral programs across herpesviruses, HBV, and HDV. Assembly Biosciences was founded in 2005 and is headquartered in South San Francisco, CA.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $466.01 +1.15%
MRNA Moderna, Inc. $221.72 -0.47%
RVMD Revolution Medicines, Inc. $191.31 +0.55%
ROIV Roivant Sciences Ltd. $36.91 -1.63%
BNTX BioNTech SE Sponsored ADR $88.17 -1.08%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.